<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>
The stock price of Emergent Biosolutions, a specialty biopharmaceutical company, has seen a fall of 15% over the last twenty-one trading days, while it is down 42% year-t0-date. EBS stock has had a tough year so far, with its manufacturing unit in Baltimore facing the heat after contamination of.
...read full article on Forbes
